Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEATRIX GBS maternal vaccination study
PACTR202603734617942Phase 3Not yet recruiting
- Sponsor
- Pfizer
- Start
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of GBS6 and Prevnar 20 in Streptococcus agalactiae infection (GBS) (2 arms), sponsored by Pfizer. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
GBS6Prevnar 20
03
Conditions
Streptococcus agalactiae infection (GBS)
Beyond the preview
Go deeper on PACTR202603734617942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603734617942.